Surgical treatment of hepatic metastases non-colorectal non-neuroendocrine tumours

• Autores: Emilio Ramos Rubio, Jaume Torras Torra, Juan Figueras Felip
• Localización: Revista de oncología: Publicación oficial de la Federación de Sociedades Españolas de Oncología y del Instituto Nacional de Cancerología de México, ISSN 1575-3018, Vol. 6, Nº. 2, 2004, págs. 86-89
• Idioma: inglés
• Texto completo no disponible (Saber más ...)
• Resumen

  • Introduction. Surgical resection is the best treatment option for hepatic metastases (HM) from colorectal carcinoma (CRC) and can be of benefit to patients with HM from neuroendocrine tumours. However, the benefit of hepatic resection in patients with HM resulting from non-colorectal non-neuroendocrine (NCRCNNE) tumours has not been established.

    The aim is to review our experience of hepatic resection in the treatment of these tumours and to evaluate the benefit with respect to survival and recurrence.

    Material and methods. Between 1992 and 2002, 20 patients with HM from NCRCNNE tumours (4 sarcomas, 5 germ-cell tumours, 5 genito-urinary tumours and 6 miscellaneous tumours) were operated-upon with curative intent. Mean age was 49±16 years.

    Results. With a mean follow-up of 17.5±11 months (range: 1-36), disease-free survival at 1 and 2 years was 50% and 25%, respectively. Overall survival over the same period was 86% and 48%, respectively. Currently, 11 patients are alive and, of whom, 8 are disease-free.

    Conclusions. Selected patients with HM resulting from NCRCNNE tumours can benefit from hepatic resection.